Antiallodynic activity of leflunomide is partially inhibited by naltrexone and glibenclamide and associated with reduced production of TNF-α and CXCL-1 - AMS, Brito; Godin, A M; PSA, Augusto (Eur J Pharmacol, 2018)
et al.